Xiongpeng Zhu
Quanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Long-term outcomes of vindesine or vincristine substitutions for vinblastine in classical Hodgkin lymphoma.
Journal: Chinese medical journal
Published: January 12, 2026
PDLIM1, a novel miR-3940-5p target, regulates the malignant progression of diffuse large B-cell lymphoma.
Journal: Cancer biology & therapy
Published: November 20, 2024
Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial.
Journal: Journal for immunotherapy of cancer
Published: October 03, 2024
Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.
Journal: Frontiers in pharmacology
Published: August 18, 2024
Combined targeting of Hedgehog/GLI1 and Wnt/β-catenin pathways in mantle cell lymphoma.
Journal: Hematological oncology
Published: April 25, 2024
Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE.
Journal: Annals of hematology
Published: January 29, 2024
Distinguishing COVID-19 from seasonal influenza in patients under age 65 years-a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics.
Journal: Frontiers in cellular and infection microbiology
Published: March 04, 2023
The effects of vaccination on the disease severity and factors for viral clearance and hospitalization in Omicron-infected patients: A retrospective observational cohort study from recent regional outbreaks in China.
Journal: Frontiers in cellular and infection microbiology
Published: July 07, 2022
APDL1-CART cells exhibit strong PD-L1-specific activity against leukemia cells.
Journal: Aging
Published: July 14, 2020
Last Updated: 09/26/2026